Close Menu

A startup company called Foundation Medicine plans to develop a lab test for doctors to analyze patient cancer samples, to determine the genetic mutations that lead to cancer, which could guide doctors in choosing the best treatment options for their patients, according to MIT's Technology Review. "As a start, the test would focus on 100 genes that have been shown scientifically to play a role in cancer treatment and progression," the Review's Courtney Humphries writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.